1
9.42
0.31 (3.40%)
Penutupan Terdahulu | 9.11 |
Buka | 9.38 |
Jumlah Dagangan | 5,012,032 |
Purata Dagangan (3B) | 3,621,336 |
Modal Pasaran | 1,159,922,304 |
Harga / Jualan (P/S) | 2.45 |
Harga / Buku (P/B) | 2.20 |
Julat 52 Minggu | |
Tarikh Pendapatan | 6 Aug 2025 - 11 Aug 2025 |
Margin Keuntungan | -25.14% |
Margin Operasi (TTM) | -31.33% |
EPS Cair (TTM) | -1.30 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 9.80% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 11.33% |
Nisbah Semasa (MRQ) | 5.37 |
Aliran Tunai Operasi (OCF TTM) | 56.74 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 95.16 M |
Pulangan Atas Aset (ROA TTM) | -12.43% |
Pulangan Atas Ekuiti (ROE TTM) | -22.03% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Health Information Services (US) | Bercampur | Bercampur |
Health Information Services (Global) | Bercampur | Bercampur | |
Stok | 10x Genomics, Inc. | Menurun | Menurun |
AISkor Stockmoo
0.5
Konsensus Penganalisis | -0.5 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 0.5 |
Purata Bergerak Teknikal | 0.0 |
Osilator Teknikal | 2.0 |
Purata | 0.50 |
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables. |
|
Sektor | Healthcare |
Industri | Health Information Services |
Gaya Pelaburan | Small Core |
% Dimiliki oleh Orang Dalam | 1.93% |
% Dimiliki oleh Institusi | 101.63% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
Venrock Management Vi, Llc | 30 Sep 2024 | 2,106,757 |
Julat 52 Minggu | ||
Julat Harga Sasaran | ||
Tinggi | 18.00 (Morgan Stanley, 91.08%) | Beli |
Median | 13.00 (38.00%) | |
Rendah | 6.50 (Goldman Sachs, -31.00%) | Jual |
Purata | 12.56 (33.33%) | |
Jumlah | 4 Beli, 3 Pegang, 1 Jual | |
Harga Purata @ Panggilan | 9.77 |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
B of A Securities | 26 Jun 2025 | 13.00 (38.00%) | Pegang | 11.70 |
Barclays | 24 Jun 2025 | 13.00 (38.00%) | Beli | 10.89 |
Morgan Stanley | 19 May 2025 | 18.00 (91.08%) | Beli | 8.93 |
Stephens & Co. | 15 May 2025 | 14.00 (48.62%) | Beli | 9.20 |
UBS | 13 May 2025 | 12.00 (27.39%) | Pegang | 9.65 |
Canaccord Genuity | 12 May 2025 | 15.00 (59.24%) | Beli | 9.49 |
Goldman Sachs | 12 May 2025 | 6.50 (-31.00%) | Jual | 9.49 |
JP Morgan | 09 May 2025 | 9.00 (-4.46%) | Pegang | 8.77 |
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
17 Jul 2025 | Pengumuman | 10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery |
10 Jul 2025 | Pengumuman | 10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025 |
14 May 2025 | Pengumuman | 10x Genomics Announces Patent Litigation Settlement Agreement with Bruker |
08 May 2025 | Pengumuman | 10x Genomics Reports First Quarter 2025 Financial Results |
30 Apr 2025 | Pengumuman | 10x Genomics to Participate in the BofA Securities 2025 Healthcare Conference |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |